- Global Pharma News & Resources

Worldwide Vaccine Delivery Devices Industry to 2026 - Featuring BD, Corium and Smiths Medical Among Others -

DUBLIN--(BUSINESS WIRE)--The "Global Vaccine Delivery Devices Market 2021-2026" report has been added to's offering.

The global market for vaccine delivery devices should grow from $3.7 billion in 2021 to $4.4 billion by 2026, at a compound annual growth rate (CAGR) of 3.8% for the period of 2021-2026.

Companies Mentioned

  • Apiject Systems Corp.
  • BD
  • Corium Inc.
  • D'antonio Consultants International Inc.
  • Enesi Pharma
  • Hindustan Syringes & Medical Devices Ltd.
  • Ichor Medical Systems Inc.
  • Kindeva Drug Delivery (Formerly 3M)
  • Medical International Technologies (Mit Canada) Inc.
  • Nanopass Technologies Ltd.
  • Pharmajet
  • Schott Ag
  • Smiths Medical
  • Terumo Corp.
  • Theraject Inc.
  • Vaxxas Pty Ltd.
  • West Pharmaceutical Services Inc.

This report provides a detailed description of vaccine delivery devices and the latest technologies in the market. The report includes market estimates for different types of vaccine delivery devices. The report also includes recent technological developments and assessments of product performance in the market.

Based on the device type, the vaccine delivery device market is segmented into syringes, jet injectors and other novel technologies (e.g., microneedle patches, electroporation-based needle-free injection system, nasal spray, etc.).

Based on the route of administration, the vaccine delivery device market is segmented into intramuscular injection, subcutaneous injection and other routes of administration (intradermal, oral route, etc.).

Based on end-users, the vaccine delivery device market is segmented into hospitals, clinics and other end-users (vaccination centers, tertiary care centers, etc.).

The report includes a list of pipeline products available in the market. The report discusses the qualitative and quantitative factors influencing the market growth, as well as market drivers, restraints and opportunities.

This report also discusses competition in the global vaccine delivery device market and the key players' strategies and performances. The discussion is focused on the major market players, trends in product launches, collaborations, and mergers and acquisitions. The report also emphasizes the company profiles of major vendors including company overview, key product offerings, financial statistics and recent developments. The report provides insights on the market share and upcoming regional demand for vaccine delivery devices.

The Report Includes

  • 55 tables
  • An overview of the global markets for vaccine delivery systems
  • Estimation of the market size and analyses of global market trends, with data from 2019, 2020, estimates for 2021 and projections of compound annual growth rates (CAGRs) through 2026
  • Identification of market drivers, restraints and other forces impacting the global market and evaluation of current market size and forecast and technological advancements and strategic innovations within the industry
  • Highlights of the market potential for vaccine delivery systems by type of device, route of administration, end user, and region
  • Discussion on vaccines limitations like inefficient activation of a cell-mediated immune response and the deficiency of protective mucosal immunity, and information on gene-based vaccines like DNA & m-RNA vaccines
  • Coverage of recent developments which have been focused on intradermal vaccine formulations for vaccine delivery devices to activate both a systemic and mucosal immune response
  • Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies
  • Profile descriptions of the leading industry players including ApiJect Systems Corp., Corium Inc., Enesi Pharma, Hindustan Syringes & Medical Devices Ltd., PharmaJet, and SCHOTT.

Key Topics Covered:

Chapter 1 Introduction

Chapter 2 Summary and Highlights

Chapter 3 Market and Technology Background

  • Vaccines and Immunization: Overview
  • Types of Vaccines
  • Attenuated (Live) Vaccines
  • Inactivated (Killed) Vaccines
  • Toxoid Vaccines
  • Subunit Vaccines
  • Conjugate Vaccines
  • Recombinant Vector Vaccines
  • DNA Vaccines
  • RNA Vaccines
  • Immunization
  • Types of Vaccine Delivery Devices
  • Syringes
  • Jet Injectors
  • Microarray Patches (Microneedle Patches)
  • Electroporation-Based Needle-Free Injections
  • Nasal Spray
  • Route of Administration
  • Injectable Route
  • Intramuscular Injections
  • Subcutaneous Injections
  • Intradermal Injections
  • Oral Route
  • Intranasal Route
  • Regulatory Aspects: Vaccine Recommendations and Guidelines of the ACIP
  • Safe Use of Needles and Syringes
  • Regulatory Pathways for Jet Injectors
  • Regulatory Pathways for Microarray Patches

Chapter 4 Impact of COVID-19 Pandemic

  • Impact of COVID-19 on Vaccine Supplies
  • Formation of COVAX
  • COVAX Facility
  • Need for COVAX
  • Impact of COVID-19 on Routine Immunization
  • Impact of COVID-19 on Syringe Supplies
  • Shortage of Low Dead-Space Specialty Syringes
  • South Korean Company to Double Syringe Supplies for a COVID-19 Vaccine Campaign
  • Optimistic Impact of COVD-19 on Syringe Manufacturers

Chapter 5 Vaccine Delivery Device Market Dynamics

  • Market Drivers
  • Growing Awareness of Immunization Across the Globe
  • Growing Investments and Support in R&D for New Vaccines
  • Rising Technological and Manufacturing Advancements in Vaccine Delivery Devices
  • Growing Incidence of Pandemic Outbreaks
  • Growing Cases of Needle Phobia
  • Market Restraints
  • Comparative High Cost of Needle-Free Technology, especially in Emerging Countries
  • Stringent Government Regulations
  • Market Opportunities
  • Opportunities in Emerging Nations
  • Competitive Landscape

Chapter 6 Market Breakdown by Device

Chapter 7 Market Breakdown by Route of Administration

Chapter 8 Market Breakdown by End User

Chapter 9 Market Breakdown by Region

Chapter 10 Market Breakdown by Type of Vaccine Technology

Chapter 11 Industry Events

Chapter 12 Key Pipeline Products

Chapter 13 Company Profiles

Chapter 14 Appendix: Acronyms

For more information about this report visit

Laura Wood, Senior Press Manager

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Editor Details

  • Company:
    • Businesswire
Last Updated: 06-Jul-2021